E-LIB Suche - Ergebnisse für: Uehara, Takeki

1

Real-World Effectiveness of Ensitrelvir in Reducing Severe ..:

Takazono, Takahiro ; Fujita, Satoki ; Komeda, Takuji...
Infectious Diseases and Therapy. , 2024

Link: https://doi.org/10.1007/..

2

Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild..:

Ohmagari, Norio ; Yotsuyanagi, Hiroshi ; Doi, Yohei...
Influenza and Other Respiratory Viruses. 18 (2024) 6 - p. , 2024

Link: https://doi.org/10.1111/..

3

Prevention of Post COVID-19 Condition by Early Treatment wi..:

Yotsuyanagi, Hiroshi ; Ohmagari, Norio ; Doi, Yohei...
Antiviral Research. , 2024

Link: https://doi.org/10.1016/..

4

Baloxavir safety and clinical and virologic outcomes in inf..:

Hirotsu, Nobuo ; Sakaguchi, Hiroki ; Fukao, Keita...
BMC Pediatrics. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

A phase 2/3 study of S-217622 in participants with SARS-CoV..:

Yotsuyanagi, Hiroshi ; Ohmagari, Norio ; Doi, Yohei...
Medicine. 102 (2023) 8 - p. e33024 , 2023

Link: https://doi.org/10.1097/..

6

Investigating the transmission of baloxavir‐resistant influ..:

Harding, Joanne ; Bernasconi, Corrado ; Williams, Sarah...
Influenza and Other Respiratory Viruses. 17 (2023) 1 - p. , 2023

Link: https://doi.org/10.1111/..

7

Baloxavir safety and clinical and virologic outcomes in inf..:

Hirotsu, Nobuo ; Sakaguchi, Hiroki ; Fukao, Keita...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860230/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Investigating the transmission of baloxavir‐resistant influ..:

Harding, Joanne ; Bernasconi, Corrado ; Williams, Sarah...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849088/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Baloxavir safety and clinical and virologic outcomes in inf..:

Nobuo Hirotsu ; Hiroki Sakaguchi ; Keita Fukao...
https://doi.org/10.1186/s12887-023-03841-5. , 2023

Link: https://doi.org/10.1186/..

10

A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral S..:

Mukae, Hiroshi ; Yotsuyanagi, Hiroshi ; Ohmagari, Norio...
Antimicrobial Agents and Chemotherapy. 66 (2022) 10 - p. , 2022

Link: https://doi.org/10.1128/..

11

Efficacy and Safety of Ensitrelvir in Patients With Mild-to..:

Mukae, Hiroshi ; Yotsuyanagi, Hiroshi ; Ohmagari, Norio...
Clinical Infectious Diseases. 76 (2022) 8 - p. 1403-1411 , 2022

Link: https://doi.org/10.1093/..

12

1133. Investigation of Treatment-Emergent Amino Acid Substi..:

Sanaki, Takao ; Baba, Keiko ; Yamamoto, Atsuko...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

13

A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral S..:

Mukae, Hiroshi ; Yotsuyanagi, Hiroshi ; Ohmagari, Norio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578433/. , 2022

Link: http://www.ncbi.nlm.nih...

14

A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral S..:

Mukae Hiroshi ; Yotsuyanagi Hiroshi ; Ohmagari Norio...
10.1128/aac.00697-22. , 2022

Link: http://hdl.handle.net/10..

15

Efficacy and Safety of Ensitrelvir in Patients With Mild-to..:

Mukae, Hiroshi ; Yotsuyanagi, Hiroshi ; Ohmagari, Norio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110269/. , 2022

Link: http://www.ncbi.nlm.nih...